Compared side by side
Epitalon vs MOTS-c: how they differ
The short answer
They are run for aging from different angles: in cell studies epitalon switches on telomerase, the enzyme that rebuilds the protective caps on chromosomes, and in mice MOTS-c, a peptide encoded by mitochondrial DNA, activates AMPK, the pathway exercise triggers. Epitalon’s research is almost all by its developers, with no independent controlled human trial, and MOTS-c hasn’t been tested in people. Epitalon runs in 10–20 day courses 2–3 times a year, MOTS-c 2–3 times a week in 4–8 week cycles.
Side by side
| Compared | Epitalon | MOTS-c |
|---|---|---|
| Category | Longevity | Longevity |
| Also known as | Epithalamin, Tetrapeptide AEDg, Epithalon | Mitochondrial Open Reading Frame of the 12S rRNA-c |
| What it is | A synthetic peptide modeled on a pineal gland extract from Russian longevity research. | A peptide encoded by your mitochondrial DNA, the energy-producing organelles inside every cell. |
| How it works | Synthetic tetrapeptide designed to match the amino-acid make-up of the pineal gland extract Epithalamin. In cell studies it activates telomerase and lengthens telomeres; in rodent studies it regulates melatonin secretion and has antioxidant effects. Studied mainly in Russian longevity research by its developers. | Mitochondria-derived peptide that regulates metabolic homeostasis. In mouse and cell studies it activates the AMPK pathway, improves insulin sensitivity and exercise capacity, and slows some signs of aging. |
| Commonly reported | Deeper sleep and more vivid dreams during a cycle, with little else to feel. The research is almost all by its developers, and no independent controlled human trial exists. | More energy and better workout endurance over the first weeks, sometimes after a week or two of feeling tired. No human trial has tested it yet. |
| Studied range | Research range: 5–10 mg. Studied in research — not a recommendation. | Research range: 5–10 mg. Studied in research — not a recommendation. |
| How often | Daily for 10–20 day cycles | 2–3× weekly |
| Half-life | Short (peptide) | Hours (short) |
| Route | SubQ injection, IM injection | SubQ injection, IM injection |
| Typical run | 10–20 day intensive cycle, 2–3 times per year. This is the most consistent community approach. | 4–8 week cycles common, 2–3× per year. Common splits: Mon/Thu (2× weekly) or Mon/Wed/Fri (3× weekly). Limited long-term human data — none on continuous dosing. |
| Evidence | Moderate: animal studies + some human data | Emerging: primarily preclinical / limited human data |
| Common side effects | Injection site reaction, mild headache, vivid dreams | Injection site reaction, mild fatigue first week |
- Category
- EpitalonLongevity
- MOTS-cLongevity
- Also known as
- EpitalonEpithalamin, Tetrapeptide AEDg, Epithalon
- MOTS-cMitochondrial Open Reading Frame of the 12S rRNA-c
- What it is
- EpitalonA synthetic peptide modeled on a pineal gland extract from Russian longevity research.
- MOTS-cA peptide encoded by your mitochondrial DNA, the energy-producing organelles inside every cell.
- How it works
- EpitalonSynthetic tetrapeptide designed to match the amino-acid make-up of the pineal gland extract Epithalamin. In cell studies it activates telomerase and lengthens telomeres; in rodent studies it regulates melatonin secretion and has antioxidant effects. Studied mainly in Russian longevity research by its developers.
- MOTS-cMitochondria-derived peptide that regulates metabolic homeostasis. In mouse and cell studies it activates the AMPK pathway, improves insulin sensitivity and exercise capacity, and slows some signs of aging.
- Commonly reported
- EpitalonDeeper sleep and more vivid dreams during a cycle, with little else to feel. The research is almost all by its developers, and no independent controlled human trial exists.
- MOTS-cMore energy and better workout endurance over the first weeks, sometimes after a week or two of feeling tired. No human trial has tested it yet.
- Studied range
- EpitalonResearch range: 5–10 mg. Studied in research — not a recommendation.
- MOTS-cResearch range: 5–10 mg. Studied in research — not a recommendation.
- How often
- EpitalonDaily for 10–20 day cycles
- MOTS-c2–3× weekly
- Half-life
- EpitalonShort (peptide)
- MOTS-cHours (short)
- Route
- EpitalonSubQ injection, IM injection
- MOTS-cSubQ injection, IM injection
- Typical run
- Epitalon10–20 day intensive cycle, 2–3 times per year. This is the most consistent community approach.
- MOTS-c4–8 week cycles common, 2–3× per year. Common splits: Mon/Thu (2× weekly) or Mon/Wed/Fri (3× weekly). Limited long-term human data — none on continuous dosing.
- Evidence
- EpitalonModerate: animal studies + some human data
- MOTS-cEmerging: primarily preclinical / limited human data
- Common side effects
- EpitalonInjection site reaction, mild headache, vivid dreams
- MOTS-cInjection site reaction, mild fatigue first week
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
Epitalon
- Day 1–5 Short, intense cycles
- Day 5–20 Deep in the cycle
MOTS-c
- Day 1–14 The first two weeks
- Day 14–28 Workouts often feel easier
- Day 28–56 Weeks 4 to 8: check your markers
- Day 56–84 Diminishing returns + cycle point
Together or one or the other
Epitalon and MOTS-c are a common stack: epitalon lists MOTS-c among its common stacks, and they’re together in the Longevity Core stack.
- Longevity Core: Mitochondrial health & cellular-aging stack (MOTS-c, Epitalon and SS-31).
Questions people ask
How long do epitalon and MOTS-c last?
The half-life of epitalon is short (peptide). The half-life of MOTS-c is hours (short).
How often are epitalon and MOTS-c taken?
Epitalon: daily for 10–20 day cycles. Routes: SubQ injection, IM injection. MOTS-c: 2–3× weekly. Routes: SubQ injection, IM injection.
How are epitalon and MOTS-c dosed in research?
The research range for epitalon is 5–10 mg. The research range for MOTS-c is 5–10 mg. Studied in research — not a recommendation.
What are the common side effects of epitalon and MOTS-c?
For epitalon, the library lists: injection site reaction, mild headache, vivid dreams. For MOTS-c: injection site reaction, mild fatigue first week.
Are epitalon and MOTS-c taken together?
Epitalon and MOTS-c are a common stack: epitalon lists MOTS-c among its common stacks, and they’re together in the Longevity Core stack.